Fifty 1 Labs, Inc. (FITY)
Fifty 1 Labs, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Melbourne, FL, US. The stock last traded at $0.00, down 50.00% on the session, giving a market capitalisation of $57,188. On trailing twelve-month figures it carries a trailing P/E of -1.42, a net margin of -37262.8%. Its beta of 2.66 implies it has historically moved more than the broad market.
Fifty 1 Labs, Inc. is a Nevada-based holding company that has shifted its focus to biotechnology and telehealth, centering on peptide science for musculoskeletal health, recovery, and performance. The company utilizes AI-driven research and aims to develop a telehealth platform for personalized peptide therapies. Formerly involved in automotive finance, the company is now pursuing growth in the functional medicine and life sciences sectors.
Fifty 1 Labs, Inc. is most often compared with the following Healthcare names: